New peer reviewed research published in Pharmaceutics demonstrates that Lonza Capsugel’s Licaps® DUOCAP® capsule in capsule technology can significantly improve protection and targeted delivery of acid sensitive enzymes in the gastrointestinal (GI) tract
Lonza Capsugel strengthens global renewable energy strategy by integrating local wind power into hard empty capsule manufacturing operations at its Bornem (BE) site through long term power purchase agreement.
Lonza Capsugel is launching UC-FLEX® collagen blend, a premium formulation for pet food that combines UC-II® undenatured type II collagen with calcium carbonate, to deliver science-backed joint health support for companion animals.
Lonza Capsugel will showcase its plant-based capsules, European manufacturing capabilities, dosage form solution expertise and health ingredients, alongside inspirational product concepts at Vitafoods Europe 2026, booth #3F72.
Lonza signs agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds, for an enterprise value of CHF 2.3 billion (USD 3 billion) at closing. The...
As part of Lonza Capsules & Health Ingredients’ (CHI) continued focus on sustainability, a new Center of Applied Sustainability has been established to accelerate...
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
Tailored offering for companies developing smart capsules includes bespoke targeted drug delivery solutions and customized capsule designs for oral biologic drugs Service...